Archives of Plastic Surgery

Korean Society of Plastic and Reconstructive Surgeons (대한성형외과학회)
권호 표지

The comparative study of treatment method on adriamycin-induced extravasation injury

Adriamycin의 혈관외 유출 손상 후 치료 방법의 비교

  • Moon, In-Sun (Department of Plastic & Reconstructive Surgery, College of Medicine. Dong-A University) ;
  • Lee, Chang-Ho (Department of Plastic & Reconstructive Surgery, College of Medicine. Dong-A University) ;
  • Kwon, Yong-Seok (Department of Plastic & Reconstructive Surgery, College of Medicine. Dong-A University) ;
  • Lee, Keun-Cheol (Department of Plastic & Reconstructive Surgery, College of Medicine. Dong-A University) ;
  • Kim, Seok-Kwun (Department of Plastic & Reconstructive Surgery, College of Medicine. Dong-A University)
  • 문인선 (동아대학교 의과대학 성형외과학교실) ;
  • 이장호 (동아대학교 의과대학 성형외과학교실) ;
  • 권용석 (동아대학교 의과대학 성형외과학교실) ;
  • 이근철 (동아대학교 의과대학 성형외과학교실) ;
  • 김석권 (동아대학교 의과대학 성형외과학교실)
  • Published : 2009.05.15
⟨ Previous Next ⟩

Abstract

Purpose: Local skin necrosis after extravasation of adriamycin, a widely used chemotherapeutic agent, is a common problem in cancer patients. The extravasation of chemotherapeutic agents yields severe inflammatory responses, crust formation, skin necrosis, and ulceration. Even though several treatment options have been proposed for extravasation injury, there is still controversy regarding the management of such lesions. Thus the aim of this study was to compare the efficacy of saline injection(Group 1), hydrocortisone injection(Group 2), propranolol injection(Group 3) and early surgical excision as a treatment(Group 4) in a rat extravasation model. Methods: The authors planned forty mature male Sprague - Dawley rats were divided into 4 groups and each group contained 10 rats. Administration of adriamycin($1.0mg/m{\ell}$) $1.5m{\ell}$ by subcutaneous injection on the dorsal side of the rats was followed by protocol. The treatment options were applied 2 hours after adriamycin injection. At the end of the 5th days, the presence and size of ulcers at the injection site were measured. 3 weeks after injection, a histopathologic examination was performed for each treatment and control group. T - tests were used to analyze the differences between the measurements. Results: Propranolol significantly improved tissue recovery compared with control group and other groups. These data suggest that there is little role for saline and hydrocortisone in the treatment of adriamycin extravasation injury. Conclusion: In this study, we compared some treatment methods in adriamycin extravasation model. The findings support the propranolol injection may prevent extravasation injury. However this study was performed in the laboratory using rats, and the results could be different in clinical application. Thus, more needs further investigations and clinical application.

Keywords

Acknowledgement

Supported by : 동아대학교

References

  1. Yilmaz M, Demirdover C, Mola F: Treatment options in extravasation injury: an experimental study in rats. Plast Reconstr Surg 109: 2418, 2002 https://doi.org/10.1097/00006534-200206000-00036
  2. Sommer NZ, Bayati S, Neumeister M, Brown RE: Dapsone for the treatment of doxorubicin extravasation injury in the rat. Plast Reconstr Surg 109: 2000, 2002 https://doi.org/10.1097/00006534-200205000-00033
  3. Harwood KV, Aisner J: Treatment of chemotherapy extravasation: current status. Cancer Treat Rev 68: 939, 1984
  4. Loth TS, Jonse DE: Extravasations of radiographic contrast material in the upper extremity. J Hand Surg 13: 395, 1988 https://doi.org/10.1016/S0363-5023(88)80016-9
  5. Gault DT: Extravasation injuries. Br J Plast Surg 46: 91, 1993 https://doi.org/10.1016/0007-1226(93)90137-Z
  6. Scuderi N, Onesti MG: Antitumor agents: extravasation, management, and surgical treatment. Ann Plast Surg 32: 39, 1994 https://doi.org/10.1097/00000637-199401000-00008
  7. Fitzpatrick JE: The cutaneous histopathology of chemotherapeutic reactions. J Cutan Pathol 20: 1, 1993 https://doi.org/10.1111/j.1600-0560.1993.tb01242.x
  8. Franchimont C, Pierard GE: Cutaneous pathobiology medited by chemotherapy. J Cutan Pathol 7: 387, 1980 https://doi.org/10.1111/j.1600-0560.1980.tb01212.x
  9. Svingen BA, Powis G, Appel PL, Scott M: Protection against adriamycin-induced skin necrosis in the rat by dimethyl sulfoxide and alapha-tocopherol. Cancer Res 41: 3395, 1981
  10. Dorr RT, Alberts DS, Stone A: Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Caner Treat Rep 69: 431, 1985
  11. Dorr RT, Alberts DS, Chen HS: The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse. Cancer Chemother Pharmacol 5: 17, 1980 https://doi.org/10.1007/BF00578557
  12. Dorr RT, Alberts DS: Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds. Cancer Res 65: 1001, 1981
  13. Larson DL: What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 75: 397, 1985 https://doi.org/10.1097/00006534-198503000-00017
  14. Yoo MS, Ahn SK, Cho EH, Lee SH: Experimental study of gross and histopathological changes after extravasation of adriamycin and efficacy of intralesional injection of steroid. Korean J Dermatol 34: 732, 1996
  15. Seul CH, Lee HK, Tark KC: Inhibitory effect of hydrocortisone on adriamycin-induced tissue necrosis. J Korean Soc Plast Reconstr Surg 26: 689, 1999